Bio-Techne Corp (FRA:TE1)
€ 76.5 1 (1.32%) Market Cap: 11.96 Bil Enterprise Value: 12.28 Bil PE Ratio: 66.51 PB Ratio: 6.55 GF Score: 92/100

Bio-Techne Corp at Citi Healthcare Services, Medtech, Tools, & HCIT Virtual Conference Transcript

Feb 25, 2021 / 02:50PM GMT
Release Date Price: €76.5 (-0.65%)
Patrick Bernard Donnelly
Citigroup Inc., Research Division - Senior Analyst

Okay. Great. Well, thank you, everyone, for joining us. I'm Patrick Donnelly, the tools and diagnostics analyst here at Citi. Happy to have Chuck Kummeth, the CEO of Bio-Techne; and Jim Hippel, the CFO.

It's going to be a Q&A. So if you have any questions, feel free to e-mail me. And Chuck, I know you wanted to start off with a few slides. So I'll turn it over to you.

Charles R. Kummeth
Bio-Techne Corporation - CEO, President & Director

Okay. I'll wait for David, to get them up here and all right. Over the next slide. I'm just going to spend a few minutes.

So just a few slides for any journalists online or people who don't know our story. So first off, with the safe harbor, I won't spend any time. You've seen this before, but of course, we have to show it.

Next slide. Bio-Techne is a 43 year old company. We're fiscal, we end in June. So as of last year, we were at $739 million. We're well north $800 million this year and climbing. We're

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot